150 related articles for article (PubMed ID: 6438245)
1. Control of epidemic meningococcal meningitis by mass vaccination. II. Persistence of antibody four years after vaccination.
Mohammed I; Onyemelukwe GC; Obineche EN; Gupta N; Oyeyinka GO
J Infect; 1984 Sep; 9(2):197-202. PubMed ID: 6438245
[TBL] [Abstract][Full Text] [Related]
2. Control of epidemic meningococcal meningitis by mass vaccination. I. Further epidemiological evaluation of groups A and C vaccines in northern Nigeria.
Mohammed I; Obineche EN; Onyemelukwe GC; Zaruba K
J Infect; 1984 Sep; 9(2):190-6. PubMed ID: 6438244
[TBL] [Abstract][Full Text] [Related]
3. Control of meningococcal infection in the African meningitis belt by selective vaccination.
Greenwood BM; Wali SS
Lancet; 1980 Apr; 1(8171):729-32. PubMed ID: 6103155
[TBL] [Abstract][Full Text] [Related]
4. Control of epidemic meningococcal meningitis by mass vaccination.
Mohammed I; Zaruba K
Lancet; 1981 Jul; 2(8237):80-2. PubMed ID: 6113451
[No Abstract] [Full Text] [Related]
5. [Survey on efficacy of inoculating purified polysaccharide vaccines as an emergency measure in preventing epidemic meningitis].
Xu CH
Zhonghua Liu Xing Bing Xue Za Zhi; 1982 Dec; 3(6):328-30. PubMed ID: 6821030
[No Abstract] [Full Text] [Related]
6. Maternal and infant antibody response to meningococcal vaccination in pregnancy.
de Andrade Carvalho A; Giampaglia CM; Kimura H; de Pereira OA; Farhat CK; Neves JC; Prandini R; da Silva Carvalho E; Zarvos AM
Lancet; 1977 Oct; 2(8042):809-11. PubMed ID: 71611
[TBL] [Abstract][Full Text] [Related]
7. [Preventive effectiveness of an urgent mass vaccination with purified meningococcal polysaccharide vaccine observed during a meningitis epidemic].
Wu C
Zhonghua Liu Xing Bing Xue Za Zhi; 1985 Dec; 6(6):344-6. PubMed ID: 3938683
[No Abstract] [Full Text] [Related]
8. Assessment of the direct effectiveness of BC meningococcal vaccine in Rio de Janeiro, Brazil: a case-control study.
Noronha CP; Struchiner CJ; Halloran ME
Int J Epidemiol; 1995 Oct; 24(5):1050-7. PubMed ID: 8557439
[TBL] [Abstract][Full Text] [Related]
9. Trial of a serogroup A meningococcus polysaccharide vaccine in Nigeria.
Sanborn WR; Bencić Z; Cvjetanović B; Gotschlich EC; Pollock TM; Sippel JE
Prog Immunobiol Stand; 1971; 5():497-505. PubMed ID: 4633977
[No Abstract] [Full Text] [Related]
10. Reactogenicity and immunogenicity of a quadrivalent combined meningococcal polysaccharide vaccine in children.
Lepow ML; Beeler J; Randolph M; Samuelson JS; Hankins WA
J Infect Dis; 1986 Dec; 154(6):1033-6. PubMed ID: 3097160
[No Abstract] [Full Text] [Related]
11. [Application of SP-RIA in the antibody surveillance and serologic diagnosis of epidemic cerebrospinal meningitis].
Chen X
Zhonghua Liu Xing Bing Xue Za Zhi; 1993 Dec; 14(6):366-70. PubMed ID: 8156584
[TBL] [Abstract][Full Text] [Related]
12. A serogroup A meningococcal polysaccharide vaccine: studies in the Sudan to combat cerebrospinal meningitis caused by Neisseria meningitidis group A.
Erwa HH; Haseeb MA; Idris AA; Lapeyssonnie L; Sanborn WR; Sippel JE
Bull World Health Organ; 1973; 49(3):301-5. PubMed ID: 4211056
[TBL] [Abstract][Full Text] [Related]
13. The immunological response to polyvalent meningococcal vaccine in Bauchi State, Nigeria.
Mohammed I; Damisah MM
Trans R Soc Trop Med Hyg; 1982; 76(3):351-3. PubMed ID: 6810520
[TBL] [Abstract][Full Text] [Related]
14. Polysaccharide meningococcal vaccines--current status.
Gold R
Hosp Pract; 1979 Dec; 14(12):41-8. PubMed ID: 116953
[TBL] [Abstract][Full Text] [Related]
15. [Immunological effectiveness of a dried group-A meningococcal polysaccharide vaccine].
Alliluev AP; Kotel'nikova OV; Chernyshova TF; Skirda TA; Kuvakina VI
Zh Mikrobiol Epidemiol Immunobiol; 1984 Mar; (3):106-12. PubMed ID: 6428089
[TBL] [Abstract][Full Text] [Related]
16. [African aspects of vaccination in prevention of purulent meningitis].
Rey M
Ann Soc Belg Med Trop; 1980 Sep; 60(3):237-52. PubMed ID: 6788000
[No Abstract] [Full Text] [Related]
17. Antibody response to serogroup A and C meningococcal polysaccharide vaccines in infants born of mothers vaccinated during pregnancy.
McCormick JB; Gusmão HH; Nakamura S; Freire JB; Veras J; Gorman G; Feeley JC; Wingo P
J Clin Invest; 1980 May; 65(5):1141-4. PubMed ID: 6767739
[TBL] [Abstract][Full Text] [Related]
18. Status of a group B Neisseria meningitidis vaccine.
Frasch CE
Eur J Clin Microbiol; 1985 Dec; 4(6):533-6. PubMed ID: 3937731
[No Abstract] [Full Text] [Related]
19. Control of group C meningococcal disease in Australian aboriginal children by mass rifampicin chemoprophylaxis and vaccination.
Pearce MC; Sheridan JW; Jones DM; Lawrence GW; Murphy DM; Masutti B; McCosker C; Douglas V; George D; O'Keefe A
Lancet; 1995 Jul; 346(8966):20-3. PubMed ID: 7603139
[TBL] [Abstract][Full Text] [Related]
20. [An epidemic of meningococcal meningitis in the region of Savanes in Togo in 1997: research and control strategies].
Aplogan A; Batchassi E; Yakoua Y; Croisier A; Aleki A; Schlumberger M; Molina S; Sidatt M; Kaninda AV
Sante; 1997; 7(6):384-90. PubMed ID: 9503496
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
